Fig. 2.

Tumor growth in FcγRIIB KO mice. E.G7 tumor cells (10⁶), LLC (10⁵) or TC-1 (10⁵) were injected s.c. into WT/FcγRIIB HT or FcγRIIB KO mice. Data represent the combined means with SD of 10–15 mice/group from two or three independent experiments (aN = 12; WT, N = 15 (8 mice cleared tumors in 15 mice and never relapsed); FcγRIIB KO, bN = 12; WT, N = 8; FcγRIIB KO, cN = 12; WT, N = 8; FcγRIIB KO). *P < 0.05, **P < 0.01 and ***P < 0.001 compared with WT/HT mice